David Kirn

David Kirn

Fortuna: 20 M $ al 30/06/2026

64 años
Health Technology
Consumer Services
Commercial Services

Perfil

David H.
Kirn
was the founder of SillaJen Biotherapeutics, Inc., founded in 2006, where the title held was President & Chief Medical Officer in 2012.
Dr. Kirn is the founder of 4D Molecular Therapeutics, Inc., founded in 2013, holding the titles of President, Chief Executive Officer & Director starting in 2026.
Dr. Kirn is also the founder of Ignite Immunotherapy, Inc...
Dr. Kirn is Chief Executive Officer at ReIGNITE Therapeutics, Inc. Dr. Kirn is Director at Coagulant Therapeutics, Inc. Dr. Kirn is Professor at the University of Oxford.
Former positions include Principal at Warner-Lambert Co., Principal at Onyx Pharmaceuticals, Inc. in 2009, Member at Harvard University, Faculty Member at The University of California, San Francisco, Advisor at National Institutes of Health, Principal at IP2IPO Innovations Ltd., and Faculty Member at Specialist Diabetes Research & Treatment Centre LLC.
Education includes an undergraduate degree from the University of California, Berkeley in 1985 and a doctorate from The University of California, San Francisco in 1989.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
10/07/2026 1.484.152 ( 2,84 % ) 20 M $ 30/06/2026

Cargos activos de David Kirn

EmpresasCargoInicio
4D MOLECULAR THERAPEUTICS, INC. Fundador 12/09/2013
Corporate Officer/Principal -
Director/Miembro de la Junta -

Antiguos cargos conocidos de David Kirn.

EmpresasCargoFin
Fundador 01/01/2019
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de David Kirn.

Formación de David Kirn.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

87

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Government

Commercial Services

Health Services

Health Technology

Health Technology

Health Technology